0HI7 logo

MeVis Medical Solutions LSE:0HI7 Stock Report

Last Price

€24.80

Market Cap

€45.1m

7D

0.8%

1Y

n/a

Updated

20 Nov, 2024

Data

Company Financials

MeVis Medical Solutions AG

LSE:0HI7 Stock Report

Market Cap: €45.1m

0HI7 Stock Overview

Develops, markets, and sells software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. More details

0HI7 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends3/6

MeVis Medical Solutions AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MeVis Medical Solutions
Historical stock prices
Current Share Price€24.80
52 Week High€25.60
52 Week Low€24.60
Beta0.0019
11 Month Changen/a
3 Month Changen/a
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO15.35%

Recent News & Updates

Recent updates

Shareholder Returns

0HI7GB Healthcare ServicesGB Market
7D0.8%-3.1%0.7%
1Yn/a23.5%6.1%

Return vs Industry: Insufficient data to determine how 0HI7 performed against the UK Healthcare Services industry.

Return vs Market: Insufficient data to determine how 0HI7 performed against the UK Market.

Price Volatility

Is 0HI7's price volatile compared to industry and market?
0HI7 volatility
0HI7 Average Weekly Movementn/a
Healthcare Services Industry Average Movement6.2%
Market Average Movement4.7%
10% most volatile stocks in GB Market10.4%
10% least volatile stocks in GB Market2.6%

Stable Share Price: 0HI7's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine 0HI7's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1997116Marcus Kirchhoffwww.mevis.de

MeVis Medical Solutions AG develops, markets, and sells software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers.

MeVis Medical Solutions AG Fundamentals Summary

How do MeVis Medical Solutions's earnings and revenue compare to its market cap?
0HI7 fundamental statistics
Market cap€45.14m
Earnings (TTM)€5.75m
Revenue (TTM)€17.64m

7.8x

P/E Ratio

2.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0HI7 income statement (TTM)
Revenue€17.64m
Cost of Revenue€10.72m
Gross Profit€6.93m
Other Expenses€1.18m
Earnings€5.75m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jan 30, 2025

Earnings per share (EPS)3.16
Gross Margin39.27%
Net Profit Margin32.60%
Debt/Equity Ratio0%

How did 0HI7 perform over the long term?

See historical performance and comparison

Dividends

3.8%

Current Dividend Yield

30%

Payout Ratio